Ligand Pharmaceuticals Stock (NASDAQ: LGND) stock price, news, charts, stock research, profile.
Open | $70.590 |
Close | - |
Volume / Avg. | 37.988K / 172.088K |
Day Range | 70.590 - 72.085 |
52 Wk Range | 49.240 - 94.570 |
Market Cap | $1.246B |
P/E Ratio | 23.224 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 5.28% |
Days to Cover | 5.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ligand Pharmaceuticals (NASDAQ: LGND) through any online brokerage.
Other companies in Ligand Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).
The latest price target for Ligand Pharmaceuticals (NASDAQ: LGND) was reported by Benchmark on Friday, April 12, 2024. The analyst firm set a price target for 95.00 expecting LGND to rise to within 12 months (a possible 33.60% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Ligand Pharmaceuticals (NASDAQ: LGND) is $71.11 last updated Today at April 26, 2024 at 3:11 PM EDT.
A quarterly cash dividend of $2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 19, 2007 to stockholders of record on April 3, 2007.
Ligand Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Ligand Pharmaceuticals.
Ligand Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.